1. Home
  2. RAYA vs QTTB Comparison

RAYA vs QTTB Comparison

Compare RAYA & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAYA
  • QTTB
  • Stock Information
  • Founded
  • RAYA 2019
  • QTTB 2015
  • Country
  • RAYA China
  • QTTB United States
  • Employees
  • RAYA N/A
  • QTTB N/A
  • Industry
  • RAYA Metal Fabrications
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAYA Consumer Discretionary
  • QTTB Health Care
  • Exchange
  • RAYA Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • RAYA 35.8M
  • QTTB 40.0M
  • IPO Year
  • RAYA 2022
  • QTTB N/A
  • Fundamental
  • Price
  • RAYA $1.30
  • QTTB $3.40
  • Analyst Decision
  • RAYA
  • QTTB Buy
  • Analyst Count
  • RAYA 0
  • QTTB 8
  • Target Price
  • RAYA N/A
  • QTTB $29.14
  • AVG Volume (30 Days)
  • RAYA 24.2K
  • QTTB 368.2K
  • Earning Date
  • RAYA 01-01-0001
  • QTTB 11-07-2024
  • Dividend Yield
  • RAYA N/A
  • QTTB N/A
  • EPS Growth
  • RAYA N/A
  • QTTB N/A
  • EPS
  • RAYA N/A
  • QTTB N/A
  • Revenue
  • RAYA $22,816,585.00
  • QTTB N/A
  • Revenue This Year
  • RAYA $64.53
  • QTTB N/A
  • Revenue Next Year
  • RAYA $9.61
  • QTTB N/A
  • P/E Ratio
  • RAYA N/A
  • QTTB N/A
  • Revenue Growth
  • RAYA N/A
  • QTTB N/A
  • 52 Week Low
  • RAYA $0.50
  • QTTB $2.99
  • 52 Week High
  • RAYA $1.78
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • RAYA 53.16
  • QTTB 23.78
  • Support Level
  • RAYA $1.13
  • QTTB $3.02
  • Resistance Level
  • RAYA $1.47
  • QTTB $3.26
  • Average True Range (ATR)
  • RAYA 0.16
  • QTTB 0.34
  • MACD
  • RAYA -0.01
  • QTTB 1.10
  • Stochastic Oscillator
  • RAYA 48.57
  • QTTB 35.34

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: